Home-based video therapy versus in-person therapy for arm recovery after stroke
Compares remote and in-person arm therapy in people who recently had a stroke.
Plain-language title generated from the registry record
Registry title: Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery
Key facts
- Where
- El Paso, United StatesSee the 3 sites
Where in United States
- Rehabilitation Sciences Complex, University of Texas at El Paso, 3333 N Mesa St, El Paso, TX 79902El Paso, United StatesTaking people
- Texas Tech University Health Sciences Center El Paso - Neurology ClinicEl Paso, United StatesTaking people
- University Medical Center of El Paso - Rehabilitation ServicesEl Paso, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Texas, El Paso
- Trial code
- NCT07661849
- Record updated
- 22 June 2026
- Original description
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care.Read full original descriptionShow less
Efficacy of Tele-CPASS, a Telerehabilitation Intervention Using Critical Periods After Stroke Study (CPASS) Compared to In-person CPASS for Upper Extremity Motor Recovery
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care.
Participants who recently experienced a stroke will be randomly assigned to receive 20 hours of upper extremity rehabilitation therapy either in person or through a telehealth platform. Both groups will receive the same type and amount of therapy focused on practicing meaningful, patient-selected daily activities. Participants will complete assessments before treatment, immediately after treatment, and at 6 and 12 months to measure recovery of arm function, real-world arm use, and participation in daily life.
The results of this study will help determine whether telerehabilitation can improve access to effective stroke recovery interventions while maintaining clinical effectiveness comparable to in-person therapy.
Inclusion: Age 21 years or older; Neuroimaging-confirmed stroke within 40 days prior to enrollment; Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item; Able to participate in all study-related activities, including 1-year follow-up; Short Blessed Memory Orientation and Concentration Scale score less than 8; Able to follow 2-step commands; Montreal Cognitive Assessment (MoCA) score greater than 25; No upper extremity injury or condition that limited upper extremity use prior to the stroke.
Exclusion: Clinically significant fluctuations in mental status within 72 hours prior to randomization; Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse; Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period; Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication; Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item; Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item; Not expected to survive 12 months because of other illnesses; Inability to provide informed consent; Pregnancy; Severe aphasia.